Narrow DCIS Margins May Not Always Warrant Reexcision - Scorecard - MDSpire

Narrow DCIS Margins May Not Always Warrant Reexcision

  • By

  • Andrea Surnit

  • July 20, 2026

  • 6 min

Share

Clinical Scorecard: Narrow DCIS Margins May Not Always Warrant Reexcision

At a Glance

CategoryDetail
ConditionDuctal Carcinoma In Situ (DCIS)
Key MechanismsAssociation of margin width with ipsilateral breast tumor recurrence (IBTR) rates.
Target PopulationPostmenopausal patients with hormone receptor-positive DCIS.
Care SettingBreast-conserving surgery and whole-breast irradiation.

Key Highlights

  • Narrower negative margins correlated with slightly higher 10-year IBTR rates.
  • Margin width not statistically significant for recurrence after adjustment for confounding factors.
  • Current guidelines recommend a 2-mm negative margin for DCIS.
  • Omission of reexcision for narrow margins may be reconsidered in selected patients.
  • Tumor size remains a significant factor for recurrence risk.

Guideline-Based Recommendations

Diagnosis

  • Assess margin width in patients undergoing breast-conserving surgery.

Management

  • Consider personalized decision-making regarding reexcision based on margin width.

Monitoring & Follow-up

  • Monitor for ipsilateral breast tumor recurrence in patients with narrow margins.

Risks

  • Higher recurrence risk associated with larger tumor size.

Patient & Prescribing Data

Postmenopausal patients with hormone receptor-positive DCIS.

65% completed 5 years of endocrine therapy, adherence did not differ by margin group.

Clinical Best Practices

  • Follow current consensus guidelines for margin width in DCIS.
  • Evaluate genomic profiles for recurrence risk assessment.

Related Resources & Content

Original Source(s)

Related Content